The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma
Open accessAbstract
BACKGROUND: Tumor cell and host immune cell interaction plays a key role in carcinogenesis. Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in cancer and believed to be an important mediator of tumor‐induced immunosuppression. This paper aims to describe the prognostic impact of neutrophil and dendritic cell infiltration in primary melanoma and the association of this infiltration with activated STAT3 (pSTAT3) in primary melanoma cells. METHODS: Formalin‐fixed, paraffin‐embedded primary melanomas from 186 stage‐I/II melanoma patients surgically resected from 1997 to 2000. Infiltrating neutrophils (CD66b), dendritic cells (CD123+ and DC‐LAMP+), T‐lymphocytes (CD8) and pSTAT3 melanoma cell expression were studied by immunohistochemistry and evaluated as present or absent. DC‐LAMP+ cell infiltration was evaluated as absent/few versus dense. Study endpoints: relapse‐free survival, melanoma‐specific, and overall survival. RESULTS: The median observation time was 12.2 years (range, 10.4‐14.2 years). Fifty‐one deaths were observed of which 38 (20%) were melanoma‐specific. In a multivariate Cox proportional hazards model including ulceration and melanoma thickness, neutrophil and CD123+ dendritic cell infiltration were independently associated with poor prognosis (CD66b: hazard ratio [HR] = 3.13; 95% confidence interval [CI], 1.43‐6.83; P = .004; CD123: HR = 2.45; 95% CI, 1.22‐4.92; P = .012). The association between melanoma cell pSTAT3 expression and immune infiltration (neutrophils and CD123+ cells) was strong. pSTAT3 expression, CD8 and DC‐LAMP infiltration were not independently associated with poor prognosis. CONCLUSIONS: Neutrophil infiltration and CD123+ dendritic cell infiltration in primary melanoma are independently associated with poor prognosis. Melanoma cell expression of pSTAT3 is strongly associated with the surrounding immune infiltrate. Cancer 2012;. © 2011 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
Clark, W. H., Elder, D. E., Guerry, D., Braitman, L. E., Trock, B. J., Schultz, D., Synnestvedt, M., & Halpern, A. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1893 · Cited by 1,247
Clemente, C. G., Mihm, M. C., Bufalino, R., Zurrida, S., Collini, P., & Cascinelli, N. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1303::aid-cncr12>3.0.co;2-5 · Cited by 1,171
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
The tumor microenvironment and its contribution to tumor evolution toward metastasis
Lorusso, G., & Rüegg, C. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0530-8 · Cited by 531
Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., & von der Maase, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9498 · Cited by 461
Self-citationImmune cells as mediators of solid tumor metastasis
DeNardo, D. G., Johansson, M., & Coussens, L. M. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9100-0 · Cited by 372
Schmidt, H., Bastholt, L., Geertsen, P., Christensen, I. J., Larsen, S., Gehl, J., & von der Maase, H. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602702 · Cited by 329
Self-citationNeutrophils: key mediators of tumour angiogenesis
Tazzyman, S., Lewis, C. E., & Murdoch, C. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00641.x · Cited by 318
Jensen, T. O., Schmidt, H., Møller, H. J., Høyer, M., Maniecki, M. B., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9919 · Cited by 299
Self-citationTaylor, R. C., Patel, A., Panageas, K. S., Busam, K. J., & Brady, M. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9755 · Cited by 297
Vermi, W., Bonecchi, R., Facchetti, F., Bianchi, D., Sozzani, S., Festa, S., Berenzi, A., Cella, M., & Colonna, M. (2003) · The Journal of Pathology · doi:10.1002/path.1344 · Cited by 295
Ladányi, A., Kiss, J., Somlai, B., Gilde, K., Fejős, Z., Mohos, A., Gaudi, I., & Tímár, J. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-007-0286-3 · Cited by 287
Targeting STAT3 affects melanoma on multiple fronts
Kortylewski, M., Jove, R., & Yu, H. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1580-1 · Cited by 280
Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?
Müller, I., Munder, M., Kropf, P., & Hänsch, G. M. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.07.007 · Cited by 277
Bellocq, A., Antoine, M., Flahault, A., Philippe, C., Crestani, B., Bernaudin, J., Mayaud, C. M., Milleron, B. J., Baud, L., & Cadranel, J. L. (1998) · PubMed Central · Cited by 228
Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses
Lande, R., & Gilliet, M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05152.x · Cited by 220
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.
Oble, D. A., Loewe, R. P., Yu, P., & Mihm, M. C. (2009) · PubMed · Cited by 207
Schmidt, H., Suciu, S., Punt, C. J. A., Gore, M., Kruit, W., Patel, P., Lienard, D., von der Maase, H., Eggermont, A. M. M., & Keilholz, U. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0274 · Cited by 190
Self-citationThe paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances
Houghton, A. M. (2010) · Cell Cycle · doi:10.4161/cc.9.9.11297 · Cited by 166
Inflammation and Cancer: A Double-Edged Sword
Hagemann, T., Balkwill, F. R., & Lawrence, T. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.005 · Cited by 157
Lin, A., Schildknecht, A., Nguyen, L. T., & Ohashi, P. S. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.09.003 · Cited by 135
CD66a, CD66b, CD66c, and CD66d each Independently stimulate neutrophils
Skubitz, K. M., Campbell, K. D., & Skubitz, A. P. N. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.1.106 · Cited by 135
Burdelya, L., Kujawski, M., Niu, G., Zhong, B., Wang, T., Zhang, S., Kortylewski, M., Shain, K., Kay, H., Djeu, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.3925 · Cited by 131
Risk Assessment in Localized Primary Cutaneous Melanoma
Tuthill, R. J., Unger, J. M., Liu, P. Y., Flaherty, L. E., & Sondak, V. K. (2002) · American Journal of Clinical Pathology · doi:10.1309/wbf7-n8kh-71kt-rvq9 · Cited by 108
The Janus face of dendritic cells in cancer
Chaput, N., Conforti, R., Viaud, S., Spatz, A., & Zitvogel, L. (2008) · Oncogene · doi:10.1038/onc.2008.270 · Cited by 90
Liang, S., Sharma, A. K., Peng, H., Robertson, G. P., & Dong, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4233 · Cited by 82
The ‘kiss of death’ by dendritic cells to cancer cells
Chan, C. W., & Housseau, F. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402235 · Cited by 76
Donskov, F. N., Hokland, M., Marcussen, N., Madsen, H. H. T., & von der Maase, H. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602937 · Cited by 72
Self-citationMessina, J. L., Yu, H., Riker, A. I., Münster, P. N., Jove, R., & DAUD, A. I. (2008) · Cancer Control · doi:10.1177/107327480801500302 · Cited by 68
The biology behind prognostic factors of cutaneous melanoma
Spatz, A., Batist, G., & Eggermont, A. M. M. (2010) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328337fe8f · Cited by 45
It is possible that tumour-infiltrating granulocytes promote tumour progression
Liu (2009) · Oncology Reports · doi:10.3892/or_00000402 · Cited by 14
Cited by
Neutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Tumour-associated neutrophils in patients with cancer
Shaul, M. E., & Fridlender, Z. G. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0222-4 · Cited by 1,023
The role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788
The CXCL8-CXCR1/2 pathways in cancer
Liu, Q., Li, A., Tian, Y., Wu, J. D., Liu, Y., Li, T., Chen, Y., Han, X., & Wu, K. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.08.002 · Cited by 662
Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
Masucci, M. T., Minopoli, M., & Carriero, M. V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01146 · Cited by 649
Metadata
- Authors
- Jensen, T. O., Schmidt, H., Møller, H. J., Donskov, F., Høyer, M., Sjoegren, P., Christensen, I. J., & Steiniche, T.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2011-09-22
- Volume
- 118
- Issue
- 9
- Pages
- 2476-2485
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1508738699
- Cited by
- 281
- References
- 38
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.